Economic Opportunity: Brand Drugs vs. Generic Drugs
| Author | Al-Badriyeh, Daoud |
| Available date | 2018-05-20T07:57:24Z |
| Publication Date | 2018-03-10 |
| Publication Name | Conference: Medication sector in Qatar: Hand in Hand Facing the blockade |
| Citation | Al-Badriyeh, Daoud. Economic Opportunity: Brand Drugs vs. Generic Drugs. Conference: Medication sector in Qatar: Hand in Hand Facing the blockade. Pharmacy collage, Qatar university. 10 March 2018. |
| Abstract | Outlines: * Pharmaceutical markets in the Middle East region are attractive *The high spending on branded drugs is unsustainable *Publicly funded health systems – increased pressure to reduce rising drug budgets *Originator (NDA) vs Generic (ANDA) review process requirements 20-90% cheaper generics * The generic drug industry is responsible for making more affordable and cost-saving medicines |
| Language | en |
| Subject | Medicine Sector - Qatar Blockade حصار قطر- القطاع الدوائي Qatar Blockade - Blockade Countries – Medicine Brand drugs - Generic drugs - Qatar Blockade |
| Type | Presentation |
Files in this item
This item appears in the following Collection(s)
-
Forums & Dialogues [57 items ]
-
Medication sector in Qatar: Hand in Hand Facing the blockade (9 – 10 March 2018) [13 items ]
-
Pharmacy Research [1314 items ]